重度甲状腺功能减退症患者的蛋白尿:一项前瞻性研究
该前瞻性观察队列研究纳入44例重度原发性甲减患者(TSH>50 µIU/mL),排除肾病、糖尿病、高血压等,给予甲状腺激素替代治疗3个月。结果显示eGFR平均升高18.25 mL/min/1.73 m2,24小时尿蛋白排泄平均减少68.39 mg/day,提示肾脏改变可逆。
要点
- 重度原发性甲减患者接受甲状腺激素替代治疗3个月后eGFR显著升高。
- 24小时尿蛋白排泄量在治疗后显著下降,提示蛋白尿可逆。
- 甲状腺激素替代治疗可能改善甲减相关的肾功能异常。
核心结论
- 甲状腺激素替代治疗可改善重度原发性甲减患者的eGFR并减少24小时尿蛋白排泄,提示肾脏改变可逆。
研究设计与样本
- 前瞻性观察性队列研究,纳入44例重度原发性甲减成人患者(血清TSH>50 µIU/mL),43例完成3个月随访。
主要发现
- 3个月时血清TSH水平下降、甲状腺素水平升高(两者P<.001)。
- eGFR平均差异为18.25±19.49 mL/min/1.73 m2(95%CI 12.25至24.25,P<.001)。
- 24小时尿蛋白排泄平均差异为-68.39±125.89 mg/day(95%CI -107.14至-29.65,P=.001)。
- 血清胆固醇和低密度脂蛋白水平也显著下降(P<.001)。
临床怎么用
- 对重度原发性甲减患者,甲状腺激素替代治疗可能同时改善肾功能和蛋白尿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Hypothyroidism is associated with reversible decline in kidney function as measured by estimated glomerular filtration rate (eGFR). eGFR and proteinuria are the most important markers for clinical assessment of kidney function. Though hypothyroidism is associated with proteinuria in cross-sectional data, the impact of treatment on proteinuria is unknown. OBJECTIVE: This study explores the effect of thyroid hormone replacement therapy on eGFR and 24-hour urine protein excretion in patients with severe primary hypothyroidism. DESIGN AND PARTICIPANTS: This study was a prospective, observational cohort study in adults with severe primary hypothyroidism (serum thyrotropin [TSH] > 50 µIU/mL). Individuals with preexisting or past kidney disease, kidney or urinary tract abnormalities, calculi or surgery, diabetes mellitus, or hypertension were excluded. The participants received thyroid hormone replacement therapy. Thyroid functions, eGFR, 24-hour urine protein excretion, and biochemical parameters were measured at baseline and 3 months. SETTING: This study took place at a single center, a tertiary care referral and teaching hospital. RESULTS: Of 44 enrolled participants, 43 completed 3 months of follow-up. At 3 months, serum TSH levels decreased and thyroxine levels increased (P < .001 for both). Significant increases in eGFR (mean difference, 18.25 ± 19.49 mL/min/1.73 m2; 95% CI, 12.25 to 24.25, P < .001) and declines in 24-hour urine protein excretion (mean difference, -68.39 ± 125.89 mg/day; 95% CI, -107.14 to -29.65, P = .001) were observed. Serum cholesterol and low-density lipoprotein levels also significantly decreased (P < .001). CONCLUSIONS: Thyroid hormone replacement therapy in patients with severe primary hypothyroidism improves eGFR and decreases 24-hour urine protein excretion, thereby suggesting reversible alterations.
引用
- Gondil VS, Chandrasekaran A, Rastogi A, et al. Proteinuria in Severe Hypothyroidism: A Prospective Study. J Clin Endocrinol Metab. 2021. PMID: 33245744. doi:10.1210/clinem/dgaa871
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。